“Classified research constitutes a much smaller portion of the U.S. biodefense program than many might suspect,” according to Gerald L. Epstein, a specialist at the Center for Strategic and International Studies.
“Nevertheless, classified DHS biodefense research will constitute one of the most controversial parts of the U.S. biodefense program,” he observed in Congressional testimony (pdf) earlier this month.
“Even more so than in other areas of science, the biological sciences have enjoyed a tradition of openness and international collaboration–and this heavy presumption of openness should continue. Since disease continues to kill millions of people around the world each year, any restrictions on relevant scientific knowledge could have serious consequences,” he told a House Science Subcommittee.
“Yet the existence of hostile, witting adversaries that are determined to wreak devastation and that are known to be interested in biological weapons mandates that this openness not be absolute.”
In March 8 testimony (at pp. 6-8), Dr. Epstein presented his views on how to reconcile these conflicting imperatives.
Wildland firefighters manage, suppress, and prescribe fires on our nation’s public lands, protecting all of us. Yet it is becoming ever clearer that we as a nation are failing to protect them.
Most patient safety challenges are not really captured and there are not enough tools to empower clinicians to improve. Here are four proposals for improving patient safety that are worthy of attention and action.
The Trump administration has often cited consolidation as a path to efficiency. But history shows that USDA reorganizations have weakened, not strengthened, the agency’s capacity.
Grace Wickerson, the Federation of American Scientists’ Senior Manager, Climate and Health, today accepted a national recognition, the “Grist 50” award, bestowed by the editorial board of Grist, a nonprofit, independent media organization.